P1497: MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED
Eduard J. van Beers(Utrecht University), Kevin H.M. Kuo(University Health Network), Rachael F. Grace(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Vanessa Beynon(Agios Pharmaceuticals (United States)), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), John B. Porter(Royal London Hospital), Parija Patel(Agios Pharmaceuticals (United States)), Melissa Dibacco(Agios Pharmaceuticals (United States)), Hanny Al‐Samkari(Harvard University), Andreas Glenthøj(University of Copenhagen), Megan Wind‐Rotolo(Bristol-Myers Squibb (United States)), Rengyi Xu(Agios Pharmaceuticals (United States))
Cited by 1
Related Papers
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
|Nature Medicine|2020|1k
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
|Cancer Cell|2020|379
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
|Blood|2014|373
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309